Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 31, Issue 1, Pages 39-48
Publisher
American Society of Clinical Oncology (ASCO)
Online
2012-11-20
DOI
10.1200/jco.2011.39.8495
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects
- (2010) J. J. Melenhorst et al. BLOOD
- Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders
- (2010) K. Jones et al. BLOOD
- Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
- (2010) A. Moosmann et al. BLOOD
- Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
- (2010) T. Feuchtinger et al. BLOOD
- Prospective Evaluation of Epstein–Barr Virus Reactivation After Stem Cell Transplantation: Association with Monoclonal Gammopathy
- (2010) Patrizia Chiusolo et al. JOURNAL OF CLINICAL IMMUNOLOGY
- How I treat EBV lymphoproliferation
- (2009) H. E. Heslop BLOOD
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation
- (2009) Michael Uhlin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Exploiting Cytokine Secretion to Rapidly Produce Multivirus-specific T Cells for Adoptive Immunotherapy
- (2009) Yuriko Fujita et al. JOURNAL OF IMMUNOTHERAPY
- Adoptive Transfer of Cytomegalovirus/Epstein-Barr Virus-specific Immune Effector Cells for Therapeutic and Preventive/Preemptive Treatment of Pediatric Allogeneic Cell Transplant Recipients
- (2009) Lujia Dong et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Identification of Natural MHC Class II Presented Phosphopeptides and Tumor-Derived MHC Class I Phospholigands
- (2009) Verena S. Meyer et al. JOURNAL OF PROTEOME RESEARCH
- Immunodeficiency-associated lymphomas
- (2008) Huy Tran et al. BLOOD REVIEWS
- Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia
- (2008) H C E Buyck et al. BONE MARROW TRANSPLANTATION
- EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT
- (2008) S Ocheni et al. BONE MARROW TRANSPLANTATION
- Epstein-Barr virus nuclear antigen 1-specific CD4+T cells directly kill Epstein-Barr virus-carrying natural killer and T cells
- (2008) Ayako Demachi-Okamura et al. CANCER SCIENCE
- Adoptive cell therapy against EBV-related malignancies: a survey of clinical results
- (2008) Anna Merlo et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Clinical Grade Generation of Hexon-specific T Cells for Adoptive T-cell Transfer as a Treatment of Adenovirus Infection After Allogeneic Stem Cell Transplantation
- (2008) Tobias Feuchtinger et al. JOURNAL OF IMMUNOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started